Weichung J. Shih
Affiliations: | Rutgers University, New Brunswick, New Brunswick, NJ, United States |
Area:
Biostatistics BiologyGoogle:
"Weichung Shih"Children
Sign in to add traineeWeili He | grad student | 2002 | Rutgers, New Brunswick |
Gaohong Dong | grad student | 2010 | Rutgers, New Brunswick |
Shiansong Li | grad student | 2014 | Rutgers, New Brunswick |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Silk AW, Kaufman HL, Curti B, et al. (2019) High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma. Frontiers in Oncology. 9: 1483 |
Portal DE, Weiss RE, Wojtowicz M, et al. (2019) Phase I neoadjuvant study of intravesical recombinant fowlpox-GM-CSF (rF-GM-CSF) or fowlpox-TRICOM (rF-TRICOM) in patients with bladder carcinoma. Cancer Gene Therapy |
Song M, Kumaran MN, Gounder M, et al. (2018) Phase I trial of selenium plus chemotherapy in gynecologic cancers. Gynecologic Oncology |
Dinizo M, Shih W, Kwon YS, et al. (2018) Multi-institution analysis of racial disparity among African-American men eligible for prostate cancer active surveillance. Oncotarget. 9: 21359-21365 |
Mehnert JM, Silk AW, Wen Y, et al. (2018) A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma. Pigment Cell & Melanoma Research |
Silk AW, Berman R, Coric V, et al. (2018) A phase I study to evaluate the safety of trigriluzole (BHV-4157) in combination with PD-1 blocking antibodies. Journal of Clinical Oncology. 36: TPS80-TPS80 |
Shih WJ, Lin Y. (2017) On study designs and hypotheses for clinical trials with predictive biomarkers. Contemporary Clinical Trials |
Lu-Yao GL, Kim S, Moore DF, et al. (2015) Primary radiotherapy vs conservative management for localized prostate cancer-a population-based study. Prostate Cancer and Prostatic Diseases |
Hirshfield KM, Lu S, Wong S, et al. (2015) Abstract P3-10-09: A Phase II trial of doxil, carboplatin and bevacizumab in metastatic triple negative breast cancer and molecular correlates of response Cancer Research. 75 |
Dinizo M, Shih W, Salmasi A, et al. (2015) MP53-04 SIGNIFICANT INTER-INSTITUTIONAL VARIATIONS IN RACIAL DISPARITIES AMONG AFRICAN-AMERICAN MEN ELIGIBLE FOR PROSTATE CANCER ACTIVE SURVEILLANCE Journal of Urology. 193 |